Response of Primary Hepatic Amyloidosis to Melphalan and Prednisone: A Case Report and Review of the Literature

MORIE A. GERTZ; ROBERT A. KYLE

doi:10.1016/S0025-6196(12)61853-9

Response of Primary Hepatic Amyloidosis to Melphalan and Prednisone: A Case Report and Review of the Literature

MORIE A. GERTZ
, ROBERT A. KYLE

Hematology

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Abstract

We report the first case of biopsy-proven primary hepatic amyloidosis in which histologic regression was demonstrated after therapy with melphalan and prednisone. On the basis of the cumulative reported experience regarding the treatment of this rare plasma cell dyscrasia, we recommend a trial of cytotoxic therapy for patients with primary hepatic amyloidosis.

Original language	English (US)
Pages (from-to)	218-223
Number of pages	6
Journal	Mayo Clinic proceedings
Volume	61
Issue number	3
DOIs	https://doi.org/10.1016/S0025-6196(12)61853-9
State	Published - 1986

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0025-6196(12)61853-9

Cite this

@article{060531bf522b416dbf8b391309da28c5,

title = "Response of Primary Hepatic Amyloidosis to Melphalan and Prednisone: A Case Report and Review of the Literature",

abstract = "We report the first case of biopsy-proven primary hepatic amyloidosis in which histologic regression was demonstrated after therapy with melphalan and prednisone. On the basis of the cumulative reported experience regarding the treatment of this rare plasma cell dyscrasia, we recommend a trial of cytotoxic therapy for patients with primary hepatic amyloidosis.",

author = "GERTZ, \{MORIE A.\} and KYLE, \{ROBERT A.\}",

year = "1986",

doi = "10.1016/S0025-6196(12)61853-9",

language = "English (US)",

volume = "61",

pages = "218--223",

journal = "Mayo Clinic proceedings",

issn = "0025-6196",

publisher = "Elsevier Ltd",

number = "3",

}

TY - JOUR

T1 - Response of Primary Hepatic Amyloidosis to Melphalan and Prednisone

T2 - A Case Report and Review of the Literature

AU - GERTZ, MORIE A.

AU - KYLE, ROBERT A.

PY - 1986

Y1 - 1986

N2 - We report the first case of biopsy-proven primary hepatic amyloidosis in which histologic regression was demonstrated after therapy with melphalan and prednisone. On the basis of the cumulative reported experience regarding the treatment of this rare plasma cell dyscrasia, we recommend a trial of cytotoxic therapy for patients with primary hepatic amyloidosis.

AB - We report the first case of biopsy-proven primary hepatic amyloidosis in which histologic regression was demonstrated after therapy with melphalan and prednisone. On the basis of the cumulative reported experience regarding the treatment of this rare plasma cell dyscrasia, we recommend a trial of cytotoxic therapy for patients with primary hepatic amyloidosis.

UR - https://www.scopus.com/pages/publications/0022534159

UR - https://www.scopus.com/pages/publications/0022534159#tab=citedBy

U2 - 10.1016/S0025-6196(12)61853-9

DO - 10.1016/S0025-6196(12)61853-9

M3 - Article

C2 - 3945122

AN - SCOPUS:0022534159

SN - 0025-6196

VL - 61

SP - 218

EP - 223

JO - Mayo Clinic proceedings

JF - Mayo Clinic proceedings

IS - 3

ER -

Response of Primary Hepatic Amyloidosis to Melphalan and Prednisone: A Case Report and Review of the Literature

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this